Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | |||
|---|---|---|---|---|---|
| Net Income | -20.28% | -11.00% | 1,298.23% | ||
| Total Depreciation and Amortization | -6.38% | -92.93% | -78.54% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -16.08% | -- | -- | ||
| Change in Net Operating Assets | -257.09% | -94.82% | -2,371.29% | ||
| Cash from Operations | -4,178.92% | -1,112.55% | -787.88% | ||
| Capital Expenditure | -- | -- | -38,391.30% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | 352,913.04% | ||
| Total Debt Issued | 183.68% | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 2,031.37% | -542.44% | -447.52% | ||
| Foreign Exchange rate Adjustments | -124.78% | 81.40% | -137.50% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 12.66% | -733.49% | 15,276.92% | ||